Direct-to-consumer prescription drug advertising and the public

Research output: Contribution to journalArticle

164 Citations (Scopus)

Abstract

OBJECTIVE: Drug manufacturers are intensely promoting their products directly to consumers, but the impact has not been widely studied. Consumers' awareness and understanding of, attitudes toward, and susceptibility to direct-to-consumer (DTC) drug advertising were examined. DESIGN: Random-digit dialing telephone survey with a random household member selection procedure (completion and response rates, 58% and 69%, respectively). SETTING: Respondents were interviewed while they were at their residences. PARTICIPANTS: Complete data were obtained from 329 adults in Sacramento County, California. MEASUREMENTS AND MAIN RESULTS: Outcome measures included awareness of advertisements for 10 selected drugs, misconceptions about DTC advertising, attitudes toward DTC ads, and behavioral responses to such promotions. The influence of demographic characteristics, health status, attitudes, beliefs, and media exposure on awareness and behaviors was examined. On average, respondents were aware of advertisements for 3.7 of the 10 drugs; awareness varied from 8% for Buspar (buspirone) to 72% for Claritin (loratadine). Awareness was associated with prescription drug use, media exposure, positive attitudes toward DTC advertising, poorer health, and insurance status. Substantial misconceptions were revealed; e.g., 43% thought that only 'completely safe' drugs could be advertised. Direct-to-consumer advertisements had led one third of respondents to ask their physicians for drug information and one fifth to request a prescription. CONCLUSIONS: Direct-to-consumer advertisements are reaching the public, but selectively so, and affecting their behaviors. Implications for public policy are examined.

Original languageEnglish (US)
Pages (from-to)651-657
Number of pages7
JournalJournal of General Internal Medicine
Volume14
Issue number11
DOIs
StatePublished - 1999

Fingerprint

Prescription Drugs
Loratadine
Pharmaceutical Preparations
Buspirone
Health Status
Attitude to Health
Insurance Coverage
Health Insurance
Public Policy
Telephone
Prescriptions
Demography
Outcome Assessment (Health Care)
Physicians
Surveys and Questionnaires
Direct-to-Consumer Advertising

Keywords

  • Advertising
  • Drug promotion
  • Drug regulation
  • Drug safety
  • Prescription drugs

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Direct-to-consumer prescription drug advertising and the public. / Bell, Robert A; Kravitz, Richard L; Wilkes, Michael S.

In: Journal of General Internal Medicine, Vol. 14, No. 11, 1999, p. 651-657.

Research output: Contribution to journalArticle

@article{34aef844db814ee894808bd60fc34e2f,
title = "Direct-to-consumer prescription drug advertising and the public",
abstract = "OBJECTIVE: Drug manufacturers are intensely promoting their products directly to consumers, but the impact has not been widely studied. Consumers' awareness and understanding of, attitudes toward, and susceptibility to direct-to-consumer (DTC) drug advertising were examined. DESIGN: Random-digit dialing telephone survey with a random household member selection procedure (completion and response rates, 58{\%} and 69{\%}, respectively). SETTING: Respondents were interviewed while they were at their residences. PARTICIPANTS: Complete data were obtained from 329 adults in Sacramento County, California. MEASUREMENTS AND MAIN RESULTS: Outcome measures included awareness of advertisements for 10 selected drugs, misconceptions about DTC advertising, attitudes toward DTC ads, and behavioral responses to such promotions. The influence of demographic characteristics, health status, attitudes, beliefs, and media exposure on awareness and behaviors was examined. On average, respondents were aware of advertisements for 3.7 of the 10 drugs; awareness varied from 8{\%} for Buspar (buspirone) to 72{\%} for Claritin (loratadine). Awareness was associated with prescription drug use, media exposure, positive attitudes toward DTC advertising, poorer health, and insurance status. Substantial misconceptions were revealed; e.g., 43{\%} thought that only 'completely safe' drugs could be advertised. Direct-to-consumer advertisements had led one third of respondents to ask their physicians for drug information and one fifth to request a prescription. CONCLUSIONS: Direct-to-consumer advertisements are reaching the public, but selectively so, and affecting their behaviors. Implications for public policy are examined.",
keywords = "Advertising, Drug promotion, Drug regulation, Drug safety, Prescription drugs",
author = "Bell, {Robert A} and Kravitz, {Richard L} and Wilkes, {Michael S}",
year = "1999",
doi = "10.1046/j.1525-1497.1999.01049.x",
language = "English (US)",
volume = "14",
pages = "651--657",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "11",

}

TY - JOUR

T1 - Direct-to-consumer prescription drug advertising and the public

AU - Bell, Robert A

AU - Kravitz, Richard L

AU - Wilkes, Michael S

PY - 1999

Y1 - 1999

N2 - OBJECTIVE: Drug manufacturers are intensely promoting their products directly to consumers, but the impact has not been widely studied. Consumers' awareness and understanding of, attitudes toward, and susceptibility to direct-to-consumer (DTC) drug advertising were examined. DESIGN: Random-digit dialing telephone survey with a random household member selection procedure (completion and response rates, 58% and 69%, respectively). SETTING: Respondents were interviewed while they were at their residences. PARTICIPANTS: Complete data were obtained from 329 adults in Sacramento County, California. MEASUREMENTS AND MAIN RESULTS: Outcome measures included awareness of advertisements for 10 selected drugs, misconceptions about DTC advertising, attitudes toward DTC ads, and behavioral responses to such promotions. The influence of demographic characteristics, health status, attitudes, beliefs, and media exposure on awareness and behaviors was examined. On average, respondents were aware of advertisements for 3.7 of the 10 drugs; awareness varied from 8% for Buspar (buspirone) to 72% for Claritin (loratadine). Awareness was associated with prescription drug use, media exposure, positive attitudes toward DTC advertising, poorer health, and insurance status. Substantial misconceptions were revealed; e.g., 43% thought that only 'completely safe' drugs could be advertised. Direct-to-consumer advertisements had led one third of respondents to ask their physicians for drug information and one fifth to request a prescription. CONCLUSIONS: Direct-to-consumer advertisements are reaching the public, but selectively so, and affecting their behaviors. Implications for public policy are examined.

AB - OBJECTIVE: Drug manufacturers are intensely promoting their products directly to consumers, but the impact has not been widely studied. Consumers' awareness and understanding of, attitudes toward, and susceptibility to direct-to-consumer (DTC) drug advertising were examined. DESIGN: Random-digit dialing telephone survey with a random household member selection procedure (completion and response rates, 58% and 69%, respectively). SETTING: Respondents were interviewed while they were at their residences. PARTICIPANTS: Complete data were obtained from 329 adults in Sacramento County, California. MEASUREMENTS AND MAIN RESULTS: Outcome measures included awareness of advertisements for 10 selected drugs, misconceptions about DTC advertising, attitudes toward DTC ads, and behavioral responses to such promotions. The influence of demographic characteristics, health status, attitudes, beliefs, and media exposure on awareness and behaviors was examined. On average, respondents were aware of advertisements for 3.7 of the 10 drugs; awareness varied from 8% for Buspar (buspirone) to 72% for Claritin (loratadine). Awareness was associated with prescription drug use, media exposure, positive attitudes toward DTC advertising, poorer health, and insurance status. Substantial misconceptions were revealed; e.g., 43% thought that only 'completely safe' drugs could be advertised. Direct-to-consumer advertisements had led one third of respondents to ask their physicians for drug information and one fifth to request a prescription. CONCLUSIONS: Direct-to-consumer advertisements are reaching the public, but selectively so, and affecting their behaviors. Implications for public policy are examined.

KW - Advertising

KW - Drug promotion

KW - Drug regulation

KW - Drug safety

KW - Prescription drugs

UR - http://www.scopus.com/inward/record.url?scp=0032735689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032735689&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1497.1999.01049.x

DO - 10.1046/j.1525-1497.1999.01049.x

M3 - Article

C2 - 10571712

AN - SCOPUS:0032735689

VL - 14

SP - 651

EP - 657

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 11

ER -